Aescuvest, founded in 2014 and based in Frankfurt, Germany, is a venture capital firm focused on the healthcare sector. Its mission is to facilitate impactful investments in medical innovations that aim to enhance healthcare delivery, products, and services. Aescuvest enables investors to create personalized portfolios of healthcare start-ups tailored to their investment interests. Through collaborations with EIT Health and a growing network of partnerships across Europe, the firm identifies and evaluates promising healthcare investment opportunities. Aescuvest employs a robust pre-screening and due diligence process, managed by an experienced Investment Committee comprised of its investment team and advisory board members with strong backgrounds in the healthcare industry. The firm's general partners actively invest their own capital in each venture, ensuring alignment of interests with their investors. By combining innovative equity capital solutions with healthcare expertise, Aescuvest offers a unique platform that helps portfolio companies develop their business solutions, accelerate commercialization, and overcome market access challenges.
XO Life operates an online platform focused on digital patient monitoring and engagement. The platform is designed to enhance patient education and support by offering real-world insights into patient preferences and treatment outcomes. It facilitates communication between patients and pharmaceutical companies, allowing for the exchange of feedback and information that improves adherence to treatments. By providing services such as patient companionship and insights into various drugs and diseases, XO Life aims to foster better relationships between patients and healthcare providers, ultimately contributing to improved patient outcomes and loyalty.
Neteera
Series B in 2023
Neteera specializes in remote contactless sensing technology that enables continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, the company detects microscopic skin motions even through clothing and furniture. This high-frequency sensing technology allows for the monitoring of various physiological parameters, including heart and respiration rates, heart rate variability, inhale-exhale ratio, and tidal volume. By focusing on seamless and safe biometric identification, Neteera provides a cost-effective solution for clients seeking to implement continuous health monitoring without the need for physical contact.
Lillian Care
Pre Seed Round in 2023
Lillian is building a nationwide network of health facilities in Germany.
Neteera
Series B in 2023
Neteera specializes in remote contactless sensing technology that enables continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, the company detects microscopic skin motions even through clothing and furniture. This high-frequency sensing technology allows for the monitoring of various physiological parameters, including heart and respiration rates, heart rate variability, inhale-exhale ratio, and tidal volume. By focusing on seamless and safe biometric identification, Neteera provides a cost-effective solution for clients seeking to implement continuous health monitoring without the need for physical contact.
Piur Imaging
Series A in 2023
Piur Imaging GmbH, founded in 2014 and headquartered in Vienna, Austria, specializes in developing innovative tomographic ultrasound technology that transforms standard ultrasound systems into advanced 3D imaging devices. Their flagship product, the PIUR tomographic ultrasound (tUS), enhances clinical applications such as endovascular aneurysm repair (EVAR) surveillance, offering superior endoleak detection and classification compared to traditional CT angiography. Additionally, the technology provides high-resolution carotid angiography for better planning of endarterectomy or stent placement and enables rapid 3D vascular mapping of superficial arteries and veins for bypass or arteriovenous fistula planning. Focused on making vascular imaging both affordable and safe, Piur's solutions leverage AI algorithms for efficient diagnostics, particularly in thyroid imaging, allowing for quick and objective analysis of thyroid nodules.
XO Life
Seed Round in 2022
XO Life operates an online platform focused on digital patient monitoring and engagement. The platform is designed to enhance patient education and support by offering real-world insights into patient preferences and treatment outcomes. It facilitates communication between patients and pharmaceutical companies, allowing for the exchange of feedback and information that improves adherence to treatments. By providing services such as patient companionship and insights into various drugs and diseases, XO Life aims to foster better relationships between patients and healthcare providers, ultimately contributing to improved patient outcomes and loyalty.
Medikura
Seed Round in 2022
MEDIKURA Digital Health GmbH, founded in 2017 and based in Munich, Germany, specializes in developing a platform focused on drug safety issues and analysis. The company offers a suite of products, including MEDIKURA Capture, which allows users to report side effects online; MEDIKURA Insights, which provides insights into drug safety and customer satisfaction; and MEDIKURA Guide, designed to help users understand the risks and benefits of their medications. Catering primarily to the pharmaceutical and insurance industries, MEDIKURA aims to enhance drug safety and improve the overall understanding of medication-related risks.
Munevo
Equity Crowdfunding in 2020
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company is known for its flagship product, munevo DRIVE, a Smartglass application that enables users to control electric wheelchairs through head movements, translating these movements into digital signals for hands-free operation. This technology provides users with greater independence and the ability to navigate both indoor and outdoor environments. In addition to the Smartglass application, Munevo also offers various adaptors and accessories to complement its solutions, further supporting the mobility needs of its users.
Emperra
Equity Crowdfunding in 2020
Emperra E-Health Technologies, founded in 2008 and located in Potsdam, Germany, specializes in developing tele-medical products for diabetes management. The company focuses on creating systems that facilitate the tracking, monitoring, and transmission of diagnostic and therapeutic data for diabetic patients. Emperra's innovative solutions include a Bluetooth-enabled insulin pen and a wireless blood glucose meter, which provide healthcare professionals with essential therapy information. These products enable doctors and nurses to effectively monitor patients' insulin doses, blood sugar levels, and carbohydrate intake, improving overall diabetes care.
Lipozyt Marker
Equity Crowdfunding in 2020
Lipozyt Marker provides oral anti-diabetic therapy. They offer a test kit that conducts mRNA analysis of the subcutaneous fatty tissue in combination with classic blood tests to determine individual causes of diabetes.
BOCAhealthcare GmbH
Equity Crowdfunding in 2020
BOCAhealth is a patented portable device (connected to an app) that is able to measure and keep track of the hydration status of a user without the need for medical personnel.
Surge-on Medical
Equity Crowdfunding in 2019
Surge-On Medical specializes in the development of innovative surgical instruments designed for minimally invasive procedures, particularly in arthroscopy and laparoscopy. The company offers steerable, detachable, and cleanable instruments that enhance surgical reachability and facilitate easier cleaning, ultimately improving the efficiency of surgical procedures. By providing surgeons with better access to challenging surgical areas, Surge-On Medical aims to advance surgical techniques and patient outcomes.
faber Biomechanik GmbH
Equity Crowdfunding in 2019
Adiuvad offers services for both in-clinic and home rehabilitation as it includes gait training. They provide a therapy device that allows the patient to get into the device from a wheelchair or bed and do walking exercises and interrupt the exercise.
Medivid GmbH
Equity Crowdfunding in 2019
Medivid is a cooling therapy for tendons, ligaments, muscles, and joints. Their therapy set contains the ingredients needed to start with consistent cooling therapy for symptoms.
MediTip-Medical MTM
Equity Crowdfunding in 2018
MediTip-Medical MTM GmbH specializes in the supply of disposable medical instruments and treatment units for healthcare providers, including doctors and hospitals. The company offers a variety of sterile, single-use products such as clamps, dental sets, needle holders, tweezers, spatulas, and spoons. All products are manufactured under stringent quality management standards tailored for medical devices, ensuring they meet the necessary safety and efficacy requirements. By providing these disposable items, MediTip-Medical MTM helps healthcare facilities minimize the risk of cross-contamination and infections, thereby enhancing patient safety and care efficiency.
Check-Up Scout GmbH
Equity Crowdfunding in 2018
Check-Up Scout provides health prevention and evidence-based medicine and self-learning processes. Additionally, they also provide health care more individuals and health care software applications.
VisionHealth
Equity Crowdfunding in 2018
VisionHealth GmbH is a healthcare technology company based in Munich, Germany, founded in 2017. It specializes in creating software solutions for patients with various respiratory diseases, particularly those reliant on inhalers for conditions such as asthma and COPD. Its primary product, Kata, is a digital healthcare assistant that utilizes artificial intelligence and machine learning to improve inhalation therapy. The application facilitates effective inhaler use by providing training and support, helping patients avoid shortness of breath and reduce the need for hospital visits. By enhancing the management of chronic lung conditions, VisionHealth aims to lower therapy costs and improve the overall quality of life for patients.
MOIO GmbH
Equity Crowdfunding in 2017
MOIO GmbH, founded in 2017 and headquartered in Fürth, Germany, develops and distributes innovative digital health solutions. Its flagship product, the moio.care system, features a sensor-based patch designed for both in-patient and out-patient care. This smart care patch can monitor user movement, trigger alarms when individuals leave defined areas, and detect falls to alert caregivers. The device can be worn comfortably on the skin using options like adhesive strips or a soft ribbon around the hips. By leveraging partnerships in research and industry, MOIO GmbH aims to continuously enhance and expand its offerings in the healthcare market, ultimately improving care for individuals in need.
epinamics
Equity Crowdfunding in 2017
Epinamics specializes in pharmaceutical research and development, focusing on innovative drug delivery technologies. The company has developed a polymer-based, sprayable, and film-forming therapeutic pump designed for dermal and transdermal applications. This technology allows for the effective delivery of medicinal drugs in high concentrations and low volumes, enhancing patient experience and outcomes. Epinamics' expertise enables it to expedite the process of bringing medical products to market, whether by utilizing existing technologies or by assisting in the development of new pharmaceutical ingredients. This commitment to innovation positions Epinamics as a valuable player in the pharmaceutical industry, particularly in the realm of advanced drug delivery systems.
Rodos BioTarget
Equity Crowdfunding in 2017
Rodos BioTarget GmbH is a biopharmaceutical company based in Hanover, Germany, founded in 2008. The company specializes in developing advanced drug delivery technologies, notably its patented TargoSphere platform. This nanocarrier system is designed to deliver a variety of therapeutic agents directly to antigen-presenting cells, thereby enhancing the immune response against infectious diseases caused by viruses, such as Hepatitis C and HIV, as well as bacterial infections like Tuberculosis and MRSA. Rodos BioTarget also offers TargoBiotics, which includes antibiotics for intracellular treatment, and TargoVir for viral infections. Additionally, the TargoSphere technology has potential applications in managing chronic inflammation, cancer, allergies, and autoimmune diseases by addressing imbalances in immune responses. The company's innovations aim to improve drug stability, biodistribution, and therapeutic efficacy.
ImmunoLogik
Equity Crowdfunding in 2017
ImmunoLogik is a biotechnology company that specializes in the discovery, development, and commercialization of antiviral drugs aimed at treating viral infections, including those caused by SARS-CoV-2. The company provides a broad-spectrum antiviral medication designed for patients infected with COVID-19, as well as therapies for various immune system disorders. ImmunoLogik is particularly focused on developing innovative treatments for HIV-positive patients, thereby enhancing the available options for healthcare professionals in managing these infections. Through its research and development efforts, ImmunoLogik aims to address both current and future challenges posed by viral diseases.
nice!innovations
Equity Crowdfunding in 2015
nice! innovations GmbH is developing a new type of external fixator system - the so-called "snakeFX".
Activoris Medizintechnik GmbH
Equity Crowdfunding in 2015
Med-Tech and pharma specialist
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.